Assure — Merger or Acquisition (May 2024)
19 slides from Assure's merger presentation, May 22, 2024
Slide 1: Investor Presentation
INVESTOR PRESENTATION May 22, 2024 I Nasdaq: IONM
Slide 2: Company Overview
COMPANY OVERVIEW
Slide 3: Historic Assure Business Model
HISTORIC ASSURE BUSINESS MODEL Assure Holdings is a healthcare services company providing best-in-class, outsourced Intraoperative NeurophysiologicalMonitoring (“IONM”) ASSURE OPERATIONS Providing technical and professional medical services IONM MEDICAL SERVICES A group of procedures used during sur
Slide 4: Overview
OVERVIEW • In September 2023, the Board of Assure directed management to evaluate strategic alternatives for the business due to rapid declines in out of network medical reimbursement rates. Management was requested to present options to retain value in the public vehicle and disposal of the clinica
Slide 5: Proposed Business Combination
PROPOSED BUSINESS COMBINATION
Slide 6: Business Combination
BUSINESS COMBINATION • On February 12, 2024, Assure entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Danam Health, Inc. (“Danam”). • Upon shareholder approval, a newly-formed subsidiary of Assure will merge with and into Danam, with Danam surviving the Merger as a wholly-ow
Slide 7: Danam Health Company Overview
GJ Danam Health ~ | COMPANY OVERVIEW
Slide 8: Executive Summary
EXECUTIVE SUMMARY Danam Health is a pharmaceutical healthcare services company providing integrated solutions across its technology platform, specialty pharmacy and wholesale operations TECH AND HUB PLATFORM • Digital pharmacy and hub platform • Nationwide network of pharmacies • Same-day local deli
Slide 9: Company Overview
COMPANY OVERVIEW Danam Health provides efficiencies, data analytics, market access and convenience for patients, pharmacies, providers, pharmaceutical manufacturers, and payors/PBMs QUICK FACTS SIGNIFICANT INDUSTRY ACCREDITATIONS PHARMACEUTICAL NETWORK VERTICAL ALIGNMENT OPPORTUNITIES • Technology P
Slide 10: Competitive Differentiation
• Provider sends Rx to pharmacy via DelivMeds • Prior Authorization services provided • Manufacturer copay or discount cards applied • Patient selects independent pharmacy via app • “Clean” Rx transferred to local pharmacy • Wellgistics provides product distribution • Community Specialty Pharm
Slide 11: Highly Attractive Business Model
HIGHLY ATTRACTIVE BUSINESS MODEL
Slide 12: Market Overview
MARKET OVERVIEW TOTAL REACH MARKET $430 Billion Total Rx drug spend + adherence + hub services market TARGET MARKET SERVED MARKET CURRENT MARKET $180 Billion Total Retail Rx market + adherence + hub services market $5.4 Billion Independent Retail Rx wholesale distribution (including specialty, l
Slide 13: Danam Health Platform
DANAM HEALTH PLATFORM Technology Platform provides comprehensive integrated solutions that drive value to key healthcare stakeholders while monetizing data, services and channel access DRIVING VALUE ACROSS THE “5-PS” PATIENT PHARMACY PROVIDER PHARMA MANUFACTURER PAYOR/ PBM Adherence Autonomy & Conve
Slide 14: Business Workflow
BUSINESS WORKFLOW Delivering interoperable solutions to key constituents across the healthcare ecosystem PHARMA MANUFACTURER DATA DATA PROVIDER PATIENT PAYOR/ PBM DATA DATA
Slide 15: Distribution, Clinical Concierge Services, Tech and Hub Platform
DISTRIBUTION CLINICAL CONCIERGE SERVICES TECH AND HUB PLATFORM
Slide 16: Health Distribution Tech & Hub Pharmacy
Health Distribution Tech & Hub Pharmacy
Slide 17: Leadership Team
Tim Canning CEO Dr. Shafaat Pirani, PharmD, BCGP EVP & CCO Brian Norton EVP Supply Chain Chuck Wilson COO LEADERSHIP TEAM Vishnu Balu VP Finance
Slide 18: Board of Directors
Suren Ajjarapu Prashant Patel Don Anderson Chairman Sajid Syed Vice Chairman Boardmember Boardmember Mr. Suren Ajjarapu is a founder/Chairman of Danam Health, Inc. Mr. Ajjarapu is an entrepreneur with leadership experience, extensive executive management, and corporate board experience. Mr. Ajjarapu
Slide 19: Additional Information and Where to Find It
Additional Information and Where to Find It This communication may be deemed to be solicitation material with respect to the proposed transactions between Assure and Danam Health Inc. In connection with the proposed transaction, Assure has filed relevant materials with the SEC, including a registrat